Andersons pediatric cardiology 1454

215.EinsenbergMJ.Rheumaticheartdiseasein
developingworld:prevalence,preventionand
control.EurHeartJ.1993;14:122–128.
216.StollermanGH.Rheumaticfeverinthe21st
century.ClinInfectDis.2001;33:806–814.
217.CatanzaroFJ,StetsonCA,MorrisAJ,etal.The
roleofStreptococcusinthepathogenesisof
rheumaticfever.AmJMed.1954;17:749–756.
218.RobertsonLA,VolmickJA,MayosiBM.
Antibioticsfortheprimarypreventionofacute
rheumaticfever:ameta-analysis.BMC
CardiovascDisord.2005;5:2–11.
219.MarkowitzM,GerberMA,KaplanEL.
Treatmentofstreptococcalpharyngitis:reports
ofpenicillin'sdemisearepremature.JPediatr.
1993;123:679–685.
220.CarapetisJ,ZühlkeLJ.Globalresearchpriorities
inrheumaticfeverandrheumaticheart.Disease.
AnnPediatrCardiol.2011;4:1–12.
221.EssopMR,PetersF.Contemporaryissuesin
rheumaticfeverandchronicrheumaticheart
disease.Circulation.2014;130:2181–2188.
222.IrlamJ,MayosiBM,EngelM,etal.Primary
preventionofacuterheumaticpharyngitis.A
Cost-effectivenessanalysis.CircCardiovasc
QualOutcomes.2013;6:343–351.
223.LennonD,KerdemelidisM,ArrollB.Meta-


analysisoftrialsofstreptococcalthroat
treatmentprogramstopreventrheumaticfever.

PediatrInfectDisJ.2009;28:e259–e264.
224.BarbosaPJB,MüllerRE,LatadoAL,etal.
Brazilianguidelinesfordiagnosis,treatmentand
preventionofrheumaticfever,Braziliansociety
ofcardiologybraziliansocietyofpediatrics,
Braziliansocietyofrheumatology.ArqBras
Cardiol.2009;93:1–18.
225.ConsensusGuidelinesonPediatricAcute
RheumaticFeverandRheumaticHeartDisease.
Workinggrouponpediatricacuterheumatic
feverandcardiologychapterofIndianacademy
ofpediatrics.IndianPediatr.2008;45:565–573.
226.MotaCCC,MeiraZMA,GracianoRN,etal.
Rheumaticfeverpreventionprogram:long-term
evolutionandoutcomes.FrontPediatr.
2015;2:141.
227.MeiraZMA,MotaCCC,TonelliE,etal.
Evaluationofsecondaryprophylacticschemes
basedonbenzathinepenicillinGforrheumatic
feverinchildren.JPediatr.1993;123:156–157.
228.LueHC,WuMH,WangJK,etal.Three-versus
four-weekadministrationofbenzathine
penicillinG:effectsonincidenceof
streptococcalinfectionsandrecurrencesof
rheumaticfever.Pediatrics.1996;97:984–988.


229.KaplanEL,BerriosX,SpethJ,etal.
PharmacokineticsofbenzathinepenicillinG:
serumlevelsduringthe28daysafter

intramuscularinjectionof1,200,000units.J
Pediatr.1989;115:146–150.
230.GinsburgCM,McCrackenGH,ZweighaftTC.
Serumpenicillinconcentrationsafter
intramuscularadministrationofbenzathine
penicillinGinchildren.Pediatrics.
1982;69:452–454.
231.KassemAS,ZaherSR,AbouShleibH,etal.
Rheumaticfeverprophylaxisusingbenzathine
penicillinG(BPG):two-weekversusfour-week
regimens:comparisonoftwobrandsofBPG.
Pediatrics.1996;97:992–995.
232.MarkowitzM,LueHC.Allergicreactionsin
rheumaticfeveronlongbenzathinepenicillinG:
theroleofskintestingforpenicillinallergy.
Pediatrics.1996;97:981–983.
233.InternationalRheumaticFeverStudyGroup.
Allergicreactionstolong-termbenzathine
penicillinprophylaxisforrheumaticfever.
Lancet.1991;337:1308–1310.